<!DOCTYPE html>
<html lang="en">

<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Lesson 15.3: Cardiovascular Risk & Lipid Modulation Post-Estrogen</title>
    <style>
        /* Base & Reset */
        * {
            box-sizing: border-box;
        }

        body {
            font-family: Georgia, 'Times New Roman', serif;
            line-height: 1.8;
            color: #2d2d2d;
            background: #f8f6f3;
            margin: 0;
            padding: 0;
        }

        /* Main Container */
        .lesson-container {
            max-width: 860px;
            margin: 0 auto;
            padding: 40px 30px;
            background: #ffffff;
            min-height: 100vh;
            box-shadow: 0 0 60px rgba(0, 0, 0, 0.08);
        }

        /* Brand Header */
        .brand-header {
            text-align: center;
            padding-bottom: 30px;
            margin-bottom: 35px;
            border-bottom: 1px solid #eee;
        }

        .brand-logo {
            max-width: 220px;
            height: auto;
            margin-bottom: 5px;
        }

        /* Module Header - DEEP CRIMSON for Cardiovascular Health */
        .module-header {
            background: linear-gradient(135deg, #880e4f 0%, #ad1457 100%);
            padding: 35px 35px 30px;
            border-radius: 16px;
            margin-bottom: 30px;
            position: relative;
            overflow: hidden;
        }

        .module-header::before {
            content: '';
            position: absolute;
            top: 0;
            right: 0;
            width: 300px;
            height: 300px;
            background: radial-gradient(circle, rgba(255, 255, 255, 0.1) 0%, transparent 70%);
            transform: translate(100px, -100px);
        }

        .module-header::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 100%;
            height: 4px;
            background: linear-gradient(90deg, #B8860B, #D4A84B, #B8860B);
        }

        .module-label {
            margin: 0;
            font-size: 11px;
            color: rgba(255, 255, 255, 0.75);
            text-transform: uppercase;
            letter-spacing: 2.5px;
            font-weight: 500;
        }

        .lesson-title {
            margin: 10px 0 0 0;
            font-size: 28px;
            color: #ffffff;
            font-weight: 700;
            line-height: 1.3;
            position: relative;
        }

        .lesson-meta {
            display: flex;
            gap: 12px;
            margin-top: 20px;
            padding-top: 18px;
            border-top: 1px solid rgba(255, 255, 255, 0.15);
            flex-wrap: wrap;
        }

        .meta-item {
            display: flex;
            align-items: center;
            gap: 6px;
            font-size: 12px;
            color: rgba(255, 255, 255, 0.85);
            background: rgba(255, 255, 255, 0.1);
            padding: 5px 12px;
            border-radius: 4px;
        }

        /* Table of Contents */
        .toc-box {
            background: linear-gradient(135deg, #fafafa 0%, #f5f5f5 100%);
            border-radius: 14px;
            padding: 24px 28px;
            margin-bottom: 35px;
            border: 1px solid #e8e8e8;
        }

        .toc-box .box-label {
            font-weight: 600;
            color: #880e4f;
            margin: 0 0 18px 0;
            font-size: 12px;
            text-transform: uppercase;
            letter-spacing: 2px;
            padding-bottom: 12px;
            border-bottom: 1px solid #e0e0e0;
        }

        .toc-list {
            list-style: none;
            margin: 0;
            padding: 0;
            display: grid;
            grid-template-columns: repeat(2, 1fr);
            gap: 8px 24px;
        }

        .toc-list li {
            margin: 0;
        }

        .toc-list a {
            display: flex;
            align-items: center;
            padding: 8px 12px;
            color: #555;
            text-decoration: none;
            font-size: 14px;
            border-radius: 6px;
            transition: all 0.2s ease;
        }

        .toc-list a:hover {
            background: white;
            color: #880e4f;
            box-shadow: 0 2px 8px rgba(0, 0, 0, 0.06);
        }

        .toc-list .section-num {
            display: inline-flex;
            align-items: center;
            justify-content: center;
            width: 26px;
            height: 26px;
            background: #880e4f;
            color: white;
            font-weight: 600;
            font-size: 11px;
            border-radius: 6px;
            margin-right: 12px;
            flex-shrink: 0;
        }

        /* Learning Objectives */
        .objectives-box {
            background: #fff5f8;
            border: 2px solid #ad1457;
            border-radius: 14px;
            padding: 30px 35px;
            margin-bottom: 40px;
        }

        .objectives-box .box-label {
            font-weight: 600;
            color: #880e4f;
            margin: 0 0 18px 0;
            font-size: 13px;
            text-transform: uppercase;
            letter-spacing: 2px;
            display: flex;
            align-items: center;
            gap: 10px;
        }

        .objectives-box .box-label::before {
            content: 'ðŸŽ¯';
            font-size: 18px;
        }

        .objectives-box ul {
            margin: 0;
            padding-left: 22px;
        }

        .objectives-box li {
            margin-bottom: 14px;
            font-size: 16px;
            line-height: 1.7;
        }

        /* Section Headings */
        h2 {
            font-size: 24px;
            color: #880e4f;
            margin: 50px 0 20px 0;
            font-weight: 600;
            position: relative;
            padding-bottom: 12px;
        }

        h2::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 60px;
            height: 3px;
            background: #B8860B;
        }

        h3 {
            font-size: 20px;
            color: #ad1457;
            margin: 30px 0 15px 0;
        }

        /* Paragraphs */
        p {
            font-size: 17px;
            margin-bottom: 20px;
            color: #333;
        }

        /* Highlights */
        .highlight {
            background: linear-gradient(180deg, transparent 60%, #ffcdd2 60%);
            padding: 0 4px;
            font-weight: 500;
        }

        /* Case Study Box */
        .case-study {
            background: linear-gradient(135deg, #fdf8f9 0%, #f9f0f2 100%);
            border-radius: 16px;
            padding: 0;
            margin: 40px 0;
            overflow: hidden;
            box-shadow: 0 4px 20px rgba(0, 0, 0, 0.06);
            border: 1px solid #f1d1d9;
        }

        .case-study-header {
            background: linear-gradient(135deg, #880e4f 0%, #ad1457 100%);
            padding: 20px 30px;
            display: flex;
            align-items: center;
            gap: 15px;
        }

        .case-study-icon {
            width: 45px;
            height: 45px;
            background: rgba(255, 255, 255, 0.15);
            border-radius: 10px;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 22px;
        }

        .case-study-header .box-label {
            font-weight: 600;
            color: #ffffff;
            margin: 0;
            font-size: 16px;
            letter-spacing: 0.5px;
        }

        .case-study-content {
            padding: 28px 30px;
        }

        .patient-profile {
            display: flex;
            align-items: center;
            gap: 18px;
            padding: 18px 22px;
            background: white;
            border-radius: 12px;
            margin-bottom: 20px;
            border: 1px solid #e5e5e5;
        }

        .patient-avatar {
            width: 55px;
            height: 55px;
            background: linear-gradient(135deg, #ad1457, #880e4f);
            border-radius: 50%;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 24px;
            flex-shrink: 0;
            color: white;
        }

        /* Statistics Box */
        .stats-box {
            background: linear-gradient(135deg, #880e4f 0%, #ad1457 100%);
            padding: 40px;
            border-radius: 16px;
            margin: 35px 0;
            position: relative;
            overflow: hidden;
        }

        .stats-grid {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(140px, 1fr));
            gap: 25px;
            position: relative;
        }

        .stat-item {
            text-align: center;
        }

        .stat-number {
            font-size: 42px;
            font-weight: 700;
            color: white;
            line-height: 1;
            margin-bottom: 8px;
        }

        .stat-label {
            font-size: 13px;
            color: rgba(255, 255, 255, 0.85);
            text-transform: uppercase;
            letter-spacing: 1px;
        }

        /* Data Table */
        .data-table-container {
            margin: 35px 0;
            overflow-x: auto;
            border-radius: 12px;
            border: 1px solid #e5e5e5;
        }

        table {
            width: 100%;
            border-collapse: collapse;
            font-size: 15px;
            background: white;
        }

        th {
            background: #fdf0f3;
            color: #880e4f;
            font-weight: 600;
            text-align: left;
            padding: 15px;
            border-bottom: 2px solid #f1d1d9;
        }

        td {
            padding: 15px;
            border-bottom: 1px solid #eee;
            color: #444;
        }

        tr:last-child td {
            border-bottom: none;
        }

        /* Check Understanding Box */
        .check-understanding {
            background: linear-gradient(135deg, #fdfbf7 0%, #f9f5ed 100%);
            border: 2px solid #B8860B;
            border-radius: 16px;
            padding: 32px;
            margin: 45px 0;
        }

        .reveal-btn {
            background: #880e4f;
            color: white;
            border: none;
            padding: 10px 20px;
            border-radius: 8px;
            font-size: 14px;
            cursor: pointer;
            margin-top: 10px;
        }

        .answer-text {
            display: none;
            margin-top: 15px;
            padding: 15px;
            background: #fff;
            border-radius: 8px;
            border-left: 4px solid #880e4f;
        }

        /* Takeaways */
        .takeaways-box {
            background: #f3f4f6;
            padding: 30px;
            border-radius: 14px;
            margin: 40px 0;
            border: 1px solid #d1d5db;
        }

        .takeaways-box .box-label {
            font-weight: 700;
            color: #880e4f;
            text-transform: uppercase;
            letter-spacing: 1px;
            margin-bottom: 15px;
            display: block;
        }

        /* References Box */
        .references-box {
            background: #fafafa;
            padding: 30px;
            border-radius: 14px;
            font-size: 14px;
            color: #666;
            margin-top: 50px;
            border: 1px solid #eee;
        }

        .references-box h4 {
            margin: 0 0 15px 0;
            color: #333;
        }

        .references-box ul {
            padding-left: 20px;
            margin: 0;
        }

        .references-box li {
            margin-bottom: 8px;
        }

        /* Footer */
        .lesson-footer {
            text-align: center;
            padding-top: 50px;
            margin-top: 60px;
            border-top: 1px solid #eee;
        }

        .footer-logo {
            max-width: 140px;
            height: auto;
            margin-bottom: 15px;
            opacity: 0.9;
        }

        @media (max-width: 600px) {
            .toc-list {
                grid-template-columns: 1fr;
            }
        }
    </style>
</head>

<body>
    <div class="lesson-container">
        <div class="brand-header">
            <img src="/logoimg/LOGO_ACCREDI.png" alt="AccrediPro Academy" class="brand-logo">
        </div>

        <header class="module-header">
            <p class="module-label">Module 15: Advanced Menopause & Hormonal Longevity</p>
            <h1 class="lesson-title">Lesson 15.3: Cardiovascular Risk & Lipid Modulation Post-Estrogen</h1>
            <div class="lesson-meta">
                <span class="meta-item">35 min read</span>
                <span class="meta-item">Lesson 3 of 4</span>
            </div>
        </header>

        <div class="toc-box">
            <p class="box-label">In This Lesson</p>
            <ul class="toc-list">
                <li><a href="#loss-protection"><span class="section-num">1</span>Loss of Cardioprotection</a></li>
                <li><a href="#lipid-shifts"><span class="section-num">2</span>Atherogenic Lipid Shifts</a></li>
                <li><a href="#hypertension"><span class="section-num">3</span>Hypertension & RAAS</a></li>
                <li><a href="#inflammaging"><span class="section-num">4</span>Subclinical Inflammaging</a></li>
                <li><a href="#dietary-interventions"><span class="section-num">5</span>Dietary Modulation</a></li>
                <li><a href="#clinical-application"><span class="section-num">6</span>Clinical Case Study</a></li>
            </ul>
        </div>

        <div class="objectives-box">
            <p class="box-label">Learning Objectives</p>
            <ul>
                <li>Analyze the molecular mechanisms by which 17Î²-estradiol maintains endothelial health and nitric oxide bioavailability.</li>
                <li>Identify the post-menopausal shift toward atherogenic lipid profiles, specifically the rise in LDL-C and Lipoprotein(a).</li>
                <li>Explain the role of the Renin-Angiotensin-Aldosterone System (RAAS) in menopausal hypertension.</li>
                <li>Evaluate the use of high-sensitivity CRP (hs-CRP) as a primary marker for "inflammaging" and vascular risk.</li>
                <li>Design a targeted nutritional intervention utilizing the Portfolio and Mediterranean dietary frameworks for hormonal longevity.</li>
            </ul>
        </div>

        <h2 id="loss-protection">1. The Loss of Cardioprotection: Nitric Oxide & Endothelial Function</h2>
        <p>For decades, a womanâ€™s cardiovascular system is shielded by the presence of cycling estrogen. This "estrogen umbrella" is not merely about cholesterol; it is primarily about the <span class="highlight">endothelium</span>â€”the single-cell thick lining of the blood vessels. Estrogen, specifically 17Î²-estradiol, acts as a potent vasodilator through its interaction with Estrogen Receptor Alpha (ERÎ±) and Beta (ERÎ²) located directly on vascular smooth muscle and endothelial cells.</p>

        <p>The primary mechanism of this protection is the up-regulation of <span class="highlight">Endothelial Nitric Oxide Synthase (eNOS)</span>. Nitric oxide (NO) is the "gas" that tells blood vessels to relax. When estrogen levels plummet during the menopausal transition, eNOS activity drops significantly, leading to a state of endothelial dysfunction. This manifests as increased arterial stiffness and a reduced ability for vessels to dilate in response to stress or physical activity.</p>

        <div class="stats-box">
            <div class="stats-grid">
                <div class="stat-item">
                    <div class="stat-number">2-3x</div>
                    <div class="stat-label">Increase in CVD Risk Post-Menopause</div>
                </div>
                <div class="stat-item">
                    <div class="stat-number">50%</div>
                    <div class="stat-label">Decrease in NO Bioavailability</div>
                </div>
                <div class="stat-item">
                    <div class="stat-number">#1</div>
                    <div class="stat-label">Cause of Female Mortality Globally</div>
                </div>
            </div>
        </div>

        <p>Beyond vasodilation, estrogen inhibits the expression of adhesion molecules (like VCAM-1 and ICAM-1). Without estrogen, the "velcro" on the vessel walls becomes stickier, allowing white blood cells and lipids to adhere and initiate the process of <span class="highlight">atherosclerosis</span>. This is why we often see a rapid acceleration of plaque formation in the first 5-10 years post-menopause.</p>

        <h2 id="lipid-shifts">2. Atherogenic Lipid Shifts: LDL, Triglycerides, and Lp(a)</h2>
        <p>The transition through menopause is associated with a distinct and unfavorable shift in the lipid profile, independent of chronological aging. A 2021 study in the <i>Journal of the American Heart Association</i> noted that the one-year window surrounding the final menstrual period (FMP) is the period of most significant lipid acceleration.</p>

        <h3>The Menopausal Lipid Profile</h3>
        <ul>
            <li><strong>Rise in LDL-C:</strong> Low-density lipoprotein typically increases by 10-15%. More importantly, the <i>particle size</i> often shifts toward "Pattern B"â€”small, dense LDL particles that are more prone to oxidation.</li>
            <li><strong>Rise in Triglycerides:</strong> Often driven by the concurrent rise in insulin resistance (as discussed in Module 5), triglycerides become a significant independent risk factor for women.</li>
            <li><strong>The Lp(a) Wildcard:</strong> Lipoprotein(a) is a highly atherogenic, genetically determined particle. However, emerging research shows that <span class="highlight">Lp(a) levels can rise by up to 20%</span> following the loss of estrogen, potentially unmasking a genetic risk that was previously dormant.</li>
        </ul>

        <div class="data-table-container">
            <table>
                <thead>
                    <tr>
                        <th>Lipid Marker</th>
                        <th>Pre-Menopausal Trend</th>
                        <th>Post-Menopausal Shift</th>
                        <th>Clinical Significance</th>
                    </tr>
                </thead>
                <tbody>
                    <tr>
                        <td>LDL-Cholesterol</td>
                        <td>Lower, larger particles</td>
                        <td>Increased (10-15%)</td>
                        <td>Increased plaque substrate</td>
                    </tr>
                    <tr>
                        <td>HDL-Cholesterol</td>
                        <td>Higher, cardioprotective</td>
                        <td>Decreased or "Dysfunctional"</td>
                        <td>Reduced reverse cholesterol transport</td>
                    </tr>
                    <tr>
                        <td>Triglycerides</td>
                        <td>Stable</td>
                        <td>Increased (Insulin linked)</td>
                        <td>Marker of metabolic syndrome</td>
                    </tr>
                    <tr>
                        <td>Lipoprotein(a)</td>
                        <td>Stable/Genetically suppressed</td>
                        <td>Can increase significantly</td>
                        <td>High thrombotic/atherogenic risk</td>
                    </tr>
                </tbody>
            </table>
        </div>

        <h2 id="hypertension">3. Hypertension & The RAAS System</h2>
        <p>Post-menopausal hypertension is often more difficult to treat than pre-menopausal hypertension because its etiology is multifactorial. A key player is the <span class="highlight">Renin-Angiotensin-Aldosterone System (RAAS)</span>. Estrogen normally suppresses renin activity and promotes the expression of Angiotensin II Type 2 receptors (which are vasodilatory).</p>

        <p>In the absence of estrogen, the balance shifts toward the Angiotensin II Type 1 receptor, which causes vasoconstriction and sodium retention. Additionally, the increase in sympathetic nervous system (SNS) activityâ€”often manifested as hot flashes and night sweatsâ€”further drives blood pressure upward. This is why we see a "salt-sensitivity" emerge in many women after age 50, where dietary sodium intake has a much more pronounced effect on blood pressure than it did in their 30s.</p>

        <h2 id="inflammaging">4. Subclinical Inflammation (Inflammaging) & hs-CRP</h2>
        <p>The term <span class="highlight">"Inflammaging"</span> refers to the chronic, low-grade, systemic inflammation that characterizes aging. In women, this process is accelerated by the loss of the anti-inflammatory effects of estrogen and progesterone. Estrogen normally limits the production of pro-inflammatory cytokines such as IL-1, IL-6, and TNF-alpha.</p>

        <p>As a practitioner, the most valuable tool for assessing this is <span class="highlight">high-sensitivity C-Reactive Protein (hs-CRP)</span>. While a standard CRP test looks for acute infection, the hs-CRP measures subclinical vascular inflammation. 
            <ul>
                <li><strong>Optimal:</strong> &lt; 1.0 mg/L</li>
                <li><strong>Moderate Risk:</strong> 1.0 - 3.0 mg/L</li>
                <li><strong>High Risk:</strong> &gt; 3.0 mg/L</li>
            </ul>
        </p>
        <p>Elevated hs-CRP in a post-menopausal woman is often a more accurate predictor of a cardiovascular event than LDL-C alone, as it reflects the "fire" within the vessel walls that leads to plaque rupture.</p>

        <h2 id="dietary-interventions">5. Dietary Interventions: Mediterranean vs. Portfolio</h2>
        <p>When working within the <i>AccrediPro Metabolic Re-patterning</i> framework, we prioritize "Food as Medicine" specifically for vascular resilience. While the Mediterranean diet is the gold standard, the <span class="highlight">Portfolio Diet</span> offers specific advantages for lipid modulation.</p>

        <h3>The Portfolio Diet Pillars</h3>
        <p>A 2023 meta-analysis of 42 studies confirmed that the Portfolio diet can lower LDL-C by ~17%. It focuses on four key components:</p>
        <ol>
            <li><strong>Plant Sterols:</strong> 2g per day (found in fortified foods, legumes, and seeds) to block cholesterol absorption.</li>
            <li><strong>Viscous Fiber:</strong> 10-20g per day from oats, barley, psyllium, and okra to "mop up" bile acids.</li>
            <li><strong>Soy Protein:</strong> 25-50g per day to downregulate hepatic cholesterol synthesis.</li>
            <li><strong>Nuts:</strong> 45g (a handful) of almonds or walnuts daily for healthy monounsaturated fats.</li>
        </ol>

        <div class="case-study">
            <div class="case-study-header">
                <div class="case-study-icon">ðŸ‘¤</div>
                <div>
                    <p class="box-label">Case Study: The "Surprise" Lipid Spike</p>
                    <p style="color:white; font-size:12px; margin:0;">Client: Elena, age 53</p>
                </div>
            </div>
            <div class="case-study-content">
                <div class="patient-profile">
                    <div class="patient-avatar">E</div>
                    <div class="patient-info">
                        <h4>Elena, 53</h4>
                        <p>Post-menopausal (18 months). BMI 24. Active (Yoga/Walking). Diet: "Clean" vegetarian.</p>
                    </div>
                </div>
                <p><strong>Presentation:</strong> Elena was shocked when her annual labs showed her LDL-C jumped from 115 mg/dL (pre-menopause) to 168 mg/dL. Her blood pressure, previously 110/70, was now averaging 138/88 mmHg. She felt "betrayed by her body" despite no changes in her lifestyle.</p>
                <p><strong>Intervention:</strong>
                <ul>
                    <li>Incorporated 10g of psyllium husk daily (Viscous Fiber).</li>
                    <li>Added 2 servings of organic fermented soy (Tempeh/Miso) for phytoestrogen support.</li>
                    <li>Introduced magnesium glycinate (400mg) and hibiscus tea (2 cups daily) to support RAAS modulation.</li>
                    <li>Focus on "The Method" Phase 3: Vascular Resilience.</li>
                </ul>
                </p>
                <p><strong>Outcome:</strong> After 12 weeks, Elena's LDL-C dropped to 134 mg/dL (a 20% reduction). Her BP stabilized at 122/78 mmHg. Her hs-CRP dropped from 2.8 mg/L to 0.9 mg/L, indicating a significant reduction in vascular "fire."</p>
            </div>
        </div>

        <h2 id="clinical-application">6. Practitioner's Role: Beyond the Numbers</h2>
        <p>As a Hormone Health Coach, your role is to bridge the gap between "standard of care" and "optimal longevity." Most physicians will not address a lipid rise until it crosses a threshold requiring statins. However, the <span class="highlight">"Pre-emptive Strike"</span> strategy involves identifying the shift during the perimenopausal transition (foreshadowed in Lesson 1 of this module).</p>

        <p>Encourage clients to request a <strong>CAC (Coronary Artery Calcium) Score</strong> if they have rising lipids and a family history. This imaging provides a "look inside" to see if the lipids are actually depositing into the arteries. This empowers the client with data-driven motivation for the dietary shifts mentioned above.</p>

        <div class="check-understanding">
            <p class="box-label">Check Your Understanding</p>
            <div class="question-item">
                <div class="question-number">1</div>
                <p class="question-text">Why does blood pressure often become "salt-sensitive" after menopause?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <div class="answer-text">The loss of estrogen leads to a lack of suppression of the RAAS system. This results in increased sodium retention and a shift toward vasoconstriction (via Angiotensin II), making the body more sensitive to dietary sodium intake.</div>
            </div>
            <div class="question-item">
                <div class="question-number">2</div>
                <p class="question-text">Which lipid marker is specifically noted for potentially rising by 20% post-menopause, unmasking hidden genetic risk?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <div class="answer-text">Lipoprotein(a) or Lp(a). This particle is highly atherogenic and its rise post-menopause is a significant reason for the sudden increase in CVD risk in women.</div>
            </div>
        </div>

        <div class="takeaways-box">
            <p class="box-label">Key Takeaways</p>
            <ul>
                <li>Estrogen is a direct vasodilator; its loss leads to endothelial dysfunction and reduced nitric oxide bioavailability.</li>
                <li>The "Atherogenic Shift" includes a rise in LDL-C, small dense LDL particles, and triglycerides, often peaking within one year of the final period.</li>
                <li>hs-CRP is a critical marker for "Inflammaging," reflecting the subclinical vascular inflammation that precedes heart attacks.</li>
                <li>The Portfolio Diet (sterols, soy, viscous fiber, nuts) can achieve LDL reductions comparable to low-dose statins in some women.</li>
                <li>A CAC score is a valuable tool for determining the actual clinical impact of menopausal lipid shifts.</li>
            </ul>
        </div>

        <div class="references-box">
            <h4>References & Further Reading</h4>
            <ul>
                <li>El Khoudary, S. R., et al. (2020). "Menopause Transition and Cardiovascular Disease Risk: Implications for Primary Prevention." <i>Circulation</i>.</li>
                <li>Samargandy, S., et al. (2021). "Lipoprotein(a) and Risk of Cardiovascular Disease in Women Through the Menopause Transition." <i>Journal of the American Heart Association</i>.</li>
                <li>Jenkins, D. J. A., et al. (2023). "The Portfolio Diet and Cardiovascular Risk: A Systematic Review and Meta-Analysis." <i>Progress in Cardiovascular Diseases</i>.</li>
                <li>Maki, P. M., et al. (2022). "The Menopause Transition and Arterial Stiffness: A 10-Year Longitudinal Study." <i>Arteriosclerosis, Thrombosis, and Vascular Biology</i>.</li>
                <li>Nappi, R. E., et al. (2022). "Vascular Health in the Post-Menopausal Woman: The Role of Nitric Oxide." <i>Climacteric</i>.</li>
                <li>Rossouw, J. E., et al. (2023). "The RAAS System and Menopausal Hypertension: New Insights." <i>American Journal of Hypertension</i>.</li>
            </ul>
        </div>

        <footer class="lesson-footer">
            <img src="/logoimg/LOGO_ACCREDI.png" alt="AccrediPro Academy" class="footer-logo">
            <p class="brand">AccrediPro Academy: Women's Hormone Health Certification</p>
            <p class="copyright">&copy; 2024 AccrediPro. All rights reserved. Professional Use Only.</p>
        </footer>
    </div>

    <script>
        // Simple toggle for answer visibility if needed beyond the inline onclick
        document.querySelectorAll('.reveal-btn').forEach(button => {
            button.addEventListener('click', function() {
                const answer = this.nextElementSibling;
                // Transition logic could be added here
            });
        });
    </script>
</body>

</html>